Dunhill Financial’s Integra LifeSciences IART Stock Holding History

Dunhill Financial’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26	Hold	1	–	–	﹤0.01%	1577
2026 Q1	$13	Hold	1	–	–	﹤0.01%	1809
2025 Q4	$18	Buy	+1	New	+$13	﹤0.01%	1929

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dunhill Financial's IART Position: Q2 2026 in Review

Dunhill Financial held its Integra LifeSciences (IART) position steady in Q2 2026 at 1 share worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Dunhill Financial first reported a position in IART in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Dunhill Financial held 1 share of Integra LifeSciences worth $26 as of Q2 2026.
Dunhill Financial left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1577 holding.
Dunhill Financial first reported a position in Integra LifeSciences in Q4 2025 and has held it in 3 quarters since.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.